Maternal diabetes and neural tube defects: Prenatal diagnosis of lumbosacral myelomeningocele, ventriculomegaly, arnold-chiari malformation and foot deformities in a pregnancy with poor maternal metabolic control, and review of the literature [3]

Genetic Counseling

Volumn 16, Issue 3, 2005, Pages 313-316

  Chen, Chih Ping ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; AMINOPTERIN; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; CARBAMAZEPINE; FOLIC ACID ANTAGONIST; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TRANSCRIPTION FACTOR PAX3; VALPROIC ACID;

ADULT; ALCOHOL CONSUMPTION; AMNIOCENTESIS; AMNION FLUID LEVEL; ANEUPLOIDY; ARNOLD CHIARI MALFORMATION; BLOOD PRESSURE MEASUREMENT; BRAIN VENTRICLE DILATATION; CASE REPORT; CHROMOSOME ABERRATION; CLUBFOOT; CONGENITAL HYDROCEPHALUS; FAMILY HISTORY; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS MALFORMATION; FOOT MALFORMATION; GENE FUNCTION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HEMOGLOBIN DETERMINATION; HIP DISLOCATION; HUMAN; KARYOTYPE 46,XX; KYPHOSCOLIOSIS; LETTER; MATERNAL AGE; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; MATERNAL NUTRITION; MENINGOMYELOCELE; METABOLIC REGULATION; NEURAL TUBE DEFECT; PRENATAL DIAGNOSIS; RISK FACTOR; SPINA BIFIDA; SPINE MALFORMATION;

ARNOLD-CHIARI MALFORMATION; CEREBRAL VENTRICLES; DIABETES MELLITUS; DRUG ADMINISTRATION SCHEDULE; FATAL OUTCOME; FEMALE; FETAL DISEASES; FOOT DEFORMITIES; HUMANS; HYPOGLYCEMIC AGENTS; LUMBOSACRAL REGION; MATERNAL BEHAVIOR; MENINGOMYELOCELE; NEURAL TUBE DEFECTS; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS;

EID: 27144476821     PISSN: 10158146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (14)

1. CHANG T.I., LOEKEN M.R.: Genotoxicity and diabetic embryopathy: impaired expression of developmental control genes as a cause of defective morphogenesis. Sem. Reprod. Endocrinol., 1999, 17, 153-165.
2. CHANG T.I., HORAL M., JAIN S.K., WANG F., PATEL R., LOEKEN M.R.: Oxidant regulation of gene expression and neural tube development: insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia, 2003, 46, 538-545.
3. CHEN C.-P., LIU F.-F., JAN S.-W., WANG K.-G., LAN C.-C.: Prenatal diagnosis of partial monosomy 13q associated with occipital encephalocele in a fetus. Prenat. Diagn., 1996, 16, 664-666.
4. CHEN C.-P., CHERN S.-R., LEE C.-C., CHEN W.-L., WANG W.: Prenatal diagnosis of mosaic ring chromosome 13 with anencephaly. Prenat. Diagn., 2001, 21, 102-105.
5. CHEN C.-P., CHERN S.-R., CHENG S.-J., CHANG T.-Y., YEH L-F., LEE C.-C., PAN C.-W., WANG W., TZEN C.-Y.: Second-trimester diagnosis of complete trisomy 9 associated with abnormal maternal serum screen results, open sacral spina bifida and congenital diaphragmatic hernia, and review of the literature. Prenat. Diagn., 2004, 24, 455-462.
6. DESESSO J.M., SCIALLI A.R., HOLSON J.F.: Apparent lability of neural tube closure in laboratory animals and humans. Am. J. Med. Genet., 1999, 87, 143-162.
7. FINE E.L., HORAL M., CHANG T.I., FORTIN G., LOEKEN M.R.: Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy. Diabetes, 1999, 48, 2454-2562.
8. HUME R.F.Jr., DRUGAN A., REICHLER A., LAMPINEN J., MARTIN L.S., JOHNSON M.P., EVANS M.I.: Aneuploidy among prenatally detected neural tube defects. Am. J. Med. Genet., 1996, 61, 171-173.
9. MARTÍNEZ-FRÍAS M.L.: Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am. J. Med. Genet., 1994, 51, 108-113.
10. MARTÍNEZ-FRÍAS M.L., BERMEJO E., RODRÍGUEZ-PINILLA E., PRIETO L., FRÍAS J.L.: Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. Am. J. Med. Genet., 1998, 78, 140-145.
11. PANI L., HORAL M., LOEKEN M.R.: Polymorphic susceptibility to the molecular causes of neural tube defects during diabetic embryopathy. Diabetes, 2002, 51, 2871-2874.
12. PANI L., HORAL M., LOEKEN M.R.: Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-depedent development and tumorigenesis. Genes Dev., 2002, 16, 676-680.
13. PHELAN S.A., ITO M., LOEKEN M.R.: Neural tube defects in embryos of diabetic mice : role of the Pax-3 gene and apoptosis. Diabetes, 1997, 46, 1189-1197.
14. RAY J.G., VERMEULEN M.J., MEIER C., WYATT P.R.: Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes. Q. J. Med. 2004, 97, 651-653.